Workplace HIV Services Provide a Turning Point for Men in Tanzania ’s Kagera Region

0
7


By Mary Goodluck Mndeme ,
Communications officer, IntraHealth International
Mary Goodluck Mndeme, Communications Officer for IntraHealth, speaks to Hamisi Kuya about his VMMC experience.November 01, 2019One morning in May 2019, I met Hamisi Kuya (36), a father of two who received voluntary medical male circumcision (VMMC) services through IntraHealth International.Hamisi lives near Kagera, in the northwestern corner of Tanzania, where he has been working at the Kagera Sugar Plantation for some years.In his area, like in many communities in the region, many people believe that the VMMC procedure is very painful and takes a long time to heal. For some of them who are sexually active, the prospect of abstaining from sex for six weeks while healing is discouraging.” After the benefits were explained to me, I became less worried about the pain and I decided to go to the clinic for the service.”Hamisi, however, learned that VMMC could help protect him from HIV, reducing his risk of acquiring the virus through heterosexual intercourseby about 60%.So, unlike some of his peers, Hamisi decided to take a daring step.“When I first heard of VMMC during a meeting with service providers from Kagera Sugar Hospital, I was so scared to go for it because I believed that it was a very painful process,” Hamisi says.“I told myself that circumcision was not for me, nor for my family and generation. However, Dr. Yustina—a medical male circumcision provider…

Source: IntraHealth InternationalCategory: International Medicine & Public Health Authors: Tags: HIV & AIDS Community Engagement Source Type: news

Related Links:

Purpose of review
Overall survival of patients with pancreatic cancer is strongly conditioned by tumor biology and the incidence of malnutrition and metabolic disorders. In this landscape, the assessment of body composition is crucial to properly manage the clinical implications of muscle wasting. The pathogenesis of this condition is the result of a complex interplay between cancer and the host. In particular, sarcopenia is induced by an inadequate nutritional intake, hormonal abnormalities, inflammation and imbalance between anabolic and catabolic pathways.
Recent findings
Recent evidences have highlighted the role …

Purpose of review
Cancer cachexia cannot be easily reversed by standard nutritional support and interventions directed at underlying metabolic derangements may be needed to prevent or reverse cachexia and maintain healthy body composition. The following review will highlight the contribution and potential therapeutic interventions for insulin resistance, alterations in ghrelin signaling, and hypogonadism in cancer patients.
Recent findings
In addition to decreased caloric intake, chronic inflammation, and altered metabolism of glucose, proteins and lipids, endocrine abnormalities can propagate weight loss or changes i…

Purpose of review
Cancer cachexia is a metabolic disturbance resulting in a loss of skeletal muscle mass that is generally not reversed through traditional nutritional interventions. We review on both the impact of nutritional status on cancer treatment side effects, as well as cancer- specific outcomes.
Recent findings
Cancer-specific cachexia and sarcopenia are associated with increased treatment-associated toxicity, and overall worse cancer-specific outcomes across all cancer types in surgical, chemotherapeutic, and radiotherapeutic populations. Despite the fact that cancer cachexia is generally thought to be irrev…

Purpose of review
Currently, several clinical trials in cancer therapy have demonstrated the success of immunomodulatory therapies. However, only a variable fraction of patients actually benefit from these treatments. The understanding of key mechanisms behind this response heterogeneity is one of the major unmet need and intense research field in immuno-oncology. This review will discuss the host metabolic dysfunctions derived from cachexia or obesity that can affect the response to cancer immunotherapy.
Recent findings
Preclinical studies demonstrated that chronic inflammation, nutritional intake impairment and endo…

Purpose of review
Systemic therapy for lung cancer is increasing in intensity and duration. European nutrition guidelines suggest screening for weight loss and malnutrition, however acknowledges there is a lack of evidence. We discuss current data round this issue and identify opportunities for further research.
Recent findings
International guidelines now exist to aid the definition of weight loss in cancer, including cachexia, sarcopenia and malnutrition. These allow consistent definition of overlapping, but distinct clinical syndromes. Nutritional status can be assessed in a range of ways including questionnaires, …

Purpose of review
Thoracic malignancies are amongst the most lethal of all cancers. Cancer cachexia lacks unanimously accepted diagnostic criteria, and therefore is referenced to as a conceptual framework whereby cancer cachexia is ‘an ongoing loss of skeletal muscle mass (termed sarcopenia), with or without loss of fat mass that cannot be reversed by conventional nutritional support and leads to progressive functional impairment’. This review summarises the current evidence base in this field, including imaging techniques currently used to define sarcopenia, inflammatory and metabolic changes associated with…

Purpose of review
Cancer cachexia is a complex inflammatory syndrome, which presents with a variety of discrete symptoms and signs. This creates a challenge for both clinicians and researchers in recognizing and assessing the syndrome. This review explores the evidence for various measures used in the assessment of cachexia.
Recent findings
Objectively, cachexia may be assessed using CT-derived measures of skeletal muscle [skeletal muscle index (SMI) and skeletal muscle density (SMD)]. Evidence suggests that SMD may be of equal or greater value than SMI in assessing cachexia. Inflammatory markers are also used, and in…

Purpose of review
To provide an updated overview of prognostic models in advanced cancer and highlight the role of prognostic calculators.
Recent findings
In the advanced cancer setting, many important healthcare decisions are driven by a patient’s prognosis. However, there is much uncertainty in formulating prognosis, particularly in the era of novel cancer therapeutics. Multiple prognostic models have been validated for patients seen by palliative care and have a life expectancy of a few months or less, such as the Palliative Performance Scale, Palliative Prognostic Score, Palliative Prognostic Index, Objective Prog…

This study evaluated the utility of ketamine and/or lidocaine in decreasing opioid consumption during acute pain episodes in adolescents with sickle cell disease. There has been an increased effort to promote opioid-sparing pain relieving methods given the ongoing opioid epidemic.
Recent findings
There have been six studies published over the past decade that highlight the ability of ketamine to reduce opioid consumption in the management of sickle cell disease-related pain, primarily in adult patients. There has been one study (2015) that demonstrated a similar benefit with lidocaine, however this was also in adult pat…

July 23, 2018A simple procedure is lowering the risk for thousands of couples in  Tanzania.Twenty-one-year-old Khadija Butemi was doing her morning chores when she heard an announcement through a loudspeaker passing by on the nearby country road.There was a campaign going on, it said, for men who wanted to undergo voluntary medical male circumcision (VMMC). She immediately thought of her husband, a 22-year-old fisherman, who was down by the lake fishing.The couple lives with their two-year-old daughter in Nansio, a remote village on the island of Ukerewe, Tanzania. VMMC isn ’t routinely offered in the area, and …

Source: IntraHealth InternationalCategory: International Medicine & Public Health Authors: Source Type: news



Source link